Good morning :)
$
₹
Goodrx Holdings Inc

Goodrx Holdings Inc

GDRX

NASDAQ
Asset Logo

Goodrx Holdings Inc

GDRX

NASDAQ
$3.600.98% (+0.03)
$
₹
$3.600.98% (+0.03)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Health Information Services

Small Cap

With a market cap of $1.2B the stock is ranked 2599

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

70.4
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.74
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$0.05
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

2.07%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 14 analysts reports

Buy
4 analysts
Hold
8 analysts
Sell
2 analysts

Price Upside

+10.64%

Earnings Growth

-13.43%

Rev. Growth

+0.2%

See Detailed Forecast

Company Profile

Company Profile

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Veeva Systems Inc Class A
VEEV
Veeva Systems Inc Class A
P/E Ratio
51.90
51.90
1Y Return
10.59%
10.59%
Buy Reco %
68.96
68.96
Doximity Inc
DOCS
Doximity Inc
P/E Ratio
39.23
39.23
1Y Return
50.55%
50.55%
Buy Reco %
38.09
38.09
Waystar Holding Corp. Common Stock
WAY
Waystar Holding Corp. Common Stock
P/E Ratio
40.01
40.01
1Y Return
23.13%
23.13%
Buy Reco %
91.30
91.30
Inspire Medical Systems Inc
INSP
Inspire Medical Systems Inc
P/E Ratio
15.71
15.71
1Y Return
14.15%
14.15%
Buy Reco %
22.22
22.22
Schrodinger Inc
SDGR
Schrodinger Inc
P/E Ratio
—
—
1Y Return
14.51%
14.51%
Buy Reco %
71.42
71.42
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 10.64% growth, versus a trailing 3-year CAGR of -12.51%.

2026
Current$3.57Baseline
Analyst Target - 1 year
Target$3.95+10.64%

All values in $

202220232024202520262027$3.67$4.90$6.14Target+10.64%
2026
Current$3.57Baseline
Analyst Target - 1 year
Target$3.95+10.64%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 0.20% growth, versus a trailing 3-year CAGR of 1.30%.

2025
Current$796.85Baseline
Forecast for Dec 2026
High$802.4+0.7%
Average$798.48+0.2%
Low$790.69-0.77%

All values in $ Million

202120222023202420252026745.42766.55750.26792.32796.85Low-0.77%Average+0.2%High+0.7%
2025
Current$796.85Baseline
Forecast for Dec 2026
High$802.4+0.7%
Average$798.48+0.2%
Low$790.69-0.77%

All values in $ Million

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -13.43% growth, versus a trailing 3-year CAGR of 5.27%.

2025
Current$0.35Baseline
Forecast for Dec 2026
High$0.34-2.86%
Average$0.3-13.43%
Low$0.29-18.49%

All values in $

2021202220232024202520260.330.30.280.330.35Low-18.49%Average-13.43%High-2.86%
2025
Current$0.35Baseline
Forecast for Dec 2026
High$0.34-2.86%
Average$0.3-13.43%
Low$0.29-18.49%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

196
1.1
194.7
5.4
194
1.1
200.4
8.5
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue197.88200.61195.25198.58202.97203.07196.02194.78194200.41
Net Income-16.6912.256.7411.0512.841.115.421.168.53
Net Profit Margin-0.50%3.33%6.27%3.39%5.44%6.32%0.57%2.78%0.60%4.25%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareHealth Information Services

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Goodrx Holdings Inc 70.41.74-
Veeva Systems Inc Class A51.905.891.20
Doximity Inc39.235.160.58
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare GDRX with any stock or ETF
Compare GDRX with any stock or ETF
Comparing from
GDRX
VEEV
DOCS
Loading...

Frequently asked questions

  1. Goodrx Holdings Inc (GDRX) share price today is $3.60 as of October 23, 2026 at 1:30 AM IST. The stock touched a day high of $3.63 and a day low of $3.55.

  2. Goodrx Holdings Inc stock trades on NASDAQ under the ticker symbol GDRX.

  3. Goodrx Holdings Inc's market capitalization is $1.2B as of October 23, 2026 at 1:30 AM IST.

  4. Goodrx Holdings Inc's price-to-earnings (P/E) ratio is 70.4 as of October 22, 2026.

  5. Goodrx Holdings Inc's price-to-book (P/B) ratio is 1.74 as of October 22, 2026.

  6. Yes, You can buy Goodrx Holdings Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Goodrx Holdings Inc shares in three steps: 1. Search Goodrx Holdings Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Goodrx Holdings Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Goodrx Holdings Inc (GDRX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 2.7739 shares at the current price of $3.60.

Loading...